News

Article

Evotec Opens Integrated Biologics Manufacturing Facility

The Just - Evotec Biologics facility in Redmond, Wash., uses the company’s J.POD technology.

Evotec SE announced the opening of its J.POD 1 late-stage clinical and commercial biologics biomanufacturing facility, in Redmond, Wash., part of Just - Evotec Biologics' J.DESIGN platform, which integrates data analytics and machine learning for the discovery, development, and manufacturing of biologic drugs.

The current good manufacturing practice (cGMP) facility, which totals 130,000 sq.ft. and uses J.POD technology, features a manufacturing ballroom and autonomous cleanrooms to run small, intensified product processes with fed-batch or continuous processing up to 1000 L scale and deliver clinical- or commercial-grade drug substance in batchs of a few kilograms to metric tons, the company reported in an Aug. 11, 2021 press statement.

The site also has dedicated quality control and process development laboratories, a warehouse, and office and meeting space for approximately 200 employees at full capacity.

The facility was constructed in 19 months, a construction schedule that is faster relative to traditional biologics manufacturing, the company reports, reducing costs and promoting sustainability. The facility is designed to use less water, electricity, and chemicals compared with conventional facilities.

"Evotec's mission is all about access to innovative, highly effective medicines.” said Evotec CEO Wener Lanthaler in a company press release. “With this uniquely flexible manufacturing facility, Evotec now has the capabilities in house to not only discover and develop innovative biologics therapies, but also deliver them to the patients who urgently need them.”

Source: Evotech

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content